Some observations on the effect of a GnRH analog in ovarian cancer
- 31 August 1989
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 32 (2) , 137-148
- https://doi.org/10.1016/0028-2243(89)90195-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- CA-125 serum concentrations during the menstrual cycleFertility and Sterility, 1988
- Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancerArchiv für Gynäkologie, 1988
- Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndromeFertility and Sterility, 1987
- Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' seraZeitschrift für Krebsforschung und Klinische Onkologie, 1986
- Elevated serum concentrations of CA-125 in patients with advanced endometriosisFertility and Sterility, 1986
- The tumor marker CA 125 is a common constituent of normal cervical mucusAmerican Journal of Obstetrics and Gynecology, 1986
- Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenAmerican Journal of Obstetrics and Gynecology, 1984
- Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125International Journal of Gynecological Pathology, 1983
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Classification and Staging of Malignant Tumours in the Female PelvisActa Obstetricia et Gynecologica Scandinavica, 1971